Mesoblast Ltd (MESO)

Mesoblast Financial Statements

Mesoblast Financial Overview

Mesoblast's market cap is currently ―. The company's EPS TTM is $-0.71; its P/E ratio is -3.46; Mesoblast is scheduled to report earnings on August 30, 2022, and the estimated EPS forecast is $-0.10. See an overview of income statement, balance sheet, and cash flow financials.
Mar 22Dec 21Sep 21Jun 21Mar 21
Income Statement
Total Revenue$ 2.01M$ 2.38M$ 3.59M$ 2.00M$ 1.91M
Gross Profit$ ―$ ―$ ―$ ―$ ―
EBIT$ -17.05M$ -21.96M$ -19.05M$ -18.06M$ -22.66M
EBITDA$ -17.05M$ -21.96M$ -19.05M$ -18.06M$ -22.66M
Net Income Common Stockholders$ -21.30M$ -25.95M$ -22.64M$ -22.06M$ -26.52M
Balance Sheet
Cash, Cash Equivalents and Short-Term Investments$ 76.31M$ 77.07M$ 94.41M$ 107.70M$ 115.96M
Total Assets$ 681.69M$ 704.44M$ 721.82M$ 744.72M$ 766.13M
Total Debt$ 54.28M$ 58.22M$ 88.09M$ 99.72M$ 118.66M
Net Debt$ -22.03M$ -18.84M$ -6.33M$ -7.98M$ 2.70M
Total Liabilities$ 164.56M$ 168.93M$ 162.07M$ 163.32M$ 165.19M
Stockholders Equity$ 517.13M$ 518.73M$ 535.51M$ 538.51M$ 559.75M
Cash Flow
Free Cash Flow$ -15.53M$ -16.84M$ -19.70M$ -25.07M$ -25.41M
Operating Cash Flow$ ―$ ―$ ―$ -20.73M$ -28.59M
Investing Cash Flow$ -56.00K$ -30.00K$ -99.00K$ -223.00K$ -936.00K
Financing Cash Flow$ -2.57M$ -4.34M$ -743.00K$ 3.69M$ 106.36M
Currency in USD

Mesoblast Earnings and Revenue History

Mesoblast Debt to Assets

Mesoblast Cash Flow

Mesoblast Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis